KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Assets (2018 - 2025)

Historic Assets for Takeda Pharmaceutical (TAK) over the last 8 years, with Q4 2025 value amounting to $100.1 billion.

  • Takeda Pharmaceutical's Assets rose 74.34% to $100.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $100.1 billion, marking a year-over-year increase of 74.34%. This contributed to the annual value of $93.5 billion for FY2025, which is 1071.72% down from last year.
  • Per Takeda Pharmaceutical's latest filing, its Assets stood at $100.1 billion for Q4 2025, which was up 74.34% from $98.2 billion recorded in Q3 2025.
  • Takeda Pharmaceutical's Assets' 5-year high stood at $122.0 billion during Q1 2021, with a 5-year trough of $93.4 billion in Q1 2025.
  • Its 5-year average for Assets is $104.6 billion, with a median of $103.6 billion in 2023.
  • In the last 5 years, Takeda Pharmaceutical's Assets surged by 359.58% in 2021 and then plummeted by 1443.13% in 2022.
  • Quarter analysis of 5 years shows Takeda Pharmaceutical's Assets stood at $111.7 billion in 2021, then dropped by 14.43% to $95.6 billion in 2022, then increased by 0.66% to $96.2 billion in 2023, then grew by 3.27% to $99.4 billion in 2024, then increased by 0.74% to $100.1 billion in 2025.
  • Its Assets was $100.1 billion in Q4 2025, compared to $98.2 billion in Q3 2025 and $96.8 billion in Q2 2025.